Ocuphire Pharma, Inc.
Ocuphire Pharma, Inc. (OCUP) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 90 transactions totaling $338.6K, demonstrating a bullish sentiment with $338.6K in net insider flow. The most recent transaction on Jun 11, 2024 involved a transaction of 41,143 shares valued at $0.
OCUP Insider Activity Summary
Who Is Buying OCUP Stock?
No significant insider buying has been recorded for OCUP in the recent period.
Who Is Selling OCUP Stock?
No significant insider selling has been recorded for OCUP in the recent period.
Is Ocuphire Pharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OCUP is bullish with an Insider Alignment Score of 100/100 and a net flow of $338.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
OCUP Frequently Asked Questions
Understanding OCUP Insider Activity
Insider trading at Ocuphire Pharma, Inc. (OCUP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading OCUP stock, having executed 90 transactions in the past 90 days. The most active insider is Susan Benton (Executive), who has made 13 transactions totaling $91.4K.
Related Tools
Track Ocuphire Pharma, Inc. Insider Activity
Get notified when executives and directors at OCUP file new Form 4 transactions